Russell Adams to Female
This is a "connection" page, showing publications Russell Adams has written about Female.
Connection Strength
0.763
-
Longitudinal stability of RBANS profiles in a geriatric community-dwelling sample. Clin Neuropsychol. 2014; 28(2):269-80.
Score: 0.036
-
Improving the diagnostic accuracy of the RBANS in mild cognitive impairment with construct-consistent measures. Appl Neuropsychol Adult. 2015; 22(1):32-41.
Score: 0.036
-
RBANS cluster profiles in a geriatric community-dwelling sample. Clin Neuropsychol. 2013; 27(5):794-807.
Score: 0.034
-
Efficacy of the ANAM General Neuropsychological Screening Battery (ANAM GNS) for detecting neurocognitive impairment in a mixed clinical sample. Clin Neuropsychol. 2013; 27(3):376-85.
Score: 0.034
-
Intersubtest discrepancies on the RBANS: results from the OKLAHOMA study. Appl Neuropsychol. 2011 Apr; 18(2):79-85.
Score: 0.030
-
Gender differences on the Repeatable Battery for the Assessment of Neuropsychological Status subtests in older adults: baseline and retest data. J Clin Exp Neuropsychol. 2011 Apr; 33(4):448-55.
Score: 0.029
-
Predicting cognitive change across 3 years in community-dwelling elders. Clin Neuropsychol. 2008 Jul; 22(4):651-61.
Score: 0.025
-
Normative data on and psychometric properties of Verbal and Visual Indexes of the RBANS in older adults. Clin Neuropsychol. 2009 Jan; 23(1):39-50.
Score: 0.024
-
Retention rates on RBANS memory subtests in elderly adults. J Geriatr Psychiatry Neurol. 2008 Mar; 21(1):26-33.
Score: 0.024
-
Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up. Pediatr Blood Cancer. 2008 Feb; 50(2):337-40.
Score: 0.024
-
Premorbid intellect and current RBANS performance: discrepancy scores in three geriatric samples. Appl Neuropsychol. 2008; 15(4):241-9.
Score: 0.024
-
Modified scoring criteria for the RBANS figures. Appl Neuropsychol. 2007; 14(2):73-83.
Score: 0.022
-
Examining the repeatable battery for the assessment of neuropsychological status: factor analytic studies in an elderly sample. Am J Geriatr Psychiatry. 2006 Nov; 14(11):976-9.
Score: 0.022
-
Test performance and classification statistics for the Rey Auditory Verbal Learning Test in selected clinical samples. Arch Clin Neuropsychol. 2006 Oct; 21(7):693-703.
Score: 0.022
-
Clinical validation of the General Ability Index--Estimate (GAI-E): estimating premorbid GAI. Clin Neuropsychol. 2006 Sep; 20(3):365-81.
Score: 0.022
-
Prediction errors of the Oklahoma Premorbid Intelligence Estimate-3 (OPIE-3) stratified by 13 age groups. Arch Clin Neuropsychol. 2006 Aug; 21(5):469-75.
Score: 0.022
-
RBANS index discrepancies: base rates for older adults. Arch Clin Neuropsychol. 2006 Feb; 21(2):151-60.
Score: 0.020
-
Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample. J Clin Exp Neuropsychol. 2005 Jul; 27(5):565-75.
Score: 0.020
-
Regression-based formulas for predicting change in RBANS subtests with older adults. Arch Clin Neuropsychol. 2005 May; 20(3):281-90.
Score: 0.020
-
Base rates of longitudinal RBANS discrepancies at one- and two-year intervals in community-dwelling older adults. Clin Neuropsychol. 2005 Feb; 19(1):27-44.
Score: 0.019
-
Development of the WAIS-III general ability index estimate (GAI-E). Clin Neuropsychol. 2005 Feb; 19(1):73-86.
Score: 0.019
-
The relationship between executive functioning and verbal and visual learning and memory. Arch Clin Neuropsychol. 2005 Jan; 20(1):111-22.
Score: 0.019
-
Predicting change with the RBANS in a community dwelling elderly sample. J Int Neuropsychol Soc. 2004 Oct; 10(6):828-34.
Score: 0.019
-
Differential estimation of verbal intelligence and performance intelligence scores from combined performance and demographic variables: the OPIE-3 verbal and performance algorithms. Clin Neuropsychol. 2004 May; 18(2):266-76.
Score: 0.018
-
The persistent belief that VIQ-PIQ splits suggest lateralized brain damage. Appl Neuropsychol. 2004; 11(2):85-90.
Score: 0.018
-
Performance of cognitively normal African Americans on the RBANS in community dwelling older adults. Clin Neuropsychol. 2003 Nov; 17(4):515-30.
Score: 0.018
-
Using the Halstead-Reitan Battery to diagnose brain damage: a comparison of the predictive power of traditional techniques to Rohling's Interpretive Method. Clin Neuropsychol. 2003 Nov; 17(4):531-43.
Score: 0.018
-
Age- and education-corrected independent normative data for the RBANS in a community dwelling elderly sample. Clin Neuropsychol. 2003 Aug; 17(3):351-66.
Score: 0.018
-
Estimation of WAIS-III intelligence from combined performance and demographic variables: development of the OPIE-3. Clin Neuropsychol. 2002 Dec; 16(4):426-37.
Score: 0.017
-
Clinical utility of the Trail Making Test practice time. Clin Neuropsychol. 1999 Nov; 13(4):450-5.
Score: 0.014
-
Base rate comparison of suboptimal scores on the RBANS effort scale and effort index in Parkinson's disease. Clin Neuropsychol. 2016 Oct; 30(7):1118-25.
Score: 0.011
-
Criterion Validity of the WAIS-IV Cognitive Proficiency Index (CPI). Clin Neuropsychol. 2015; 29(6):777-87.
Score: 0.010
-
The development of verbal and nonverbal factorially derived memory measures. J Clin Psychol. 1993 Jan; 49(1):89-94.
Score: 0.008
-
Brief report: the temporal stability of the Repeatable Battery for the Assessment of Neuropsychological Status Effort Index in geriatric samples. Arch Clin Neuropsychol. 2012 Jan; 27(1):114-8.
Score: 0.008
-
Clinical validity of the Speech-Sounds Perception Test and the Seashore Rhythm Test. J Clin Exp Neuropsychol. 1991 Sep; 13(5):741-51.
Score: 0.008
-
The RBANS Effort Index: base rates in geriatric samples. Appl Neuropsychol. 2011 Jan; 18(1):11-7.
Score: 0.007
-
Assessment of the RBANS Visual and Verbal Indices in a sample of neurologically impaired elderly participants. Clin Neuropsychol. 2010 Nov; 24(8):1365-78.
Score: 0.007
-
Partial cross-validation of the Wechsler Memory Scale-Revised (WMS-R) General Memory-Attention/Concentration Malingering Index in a nonlitigating sample. Arch Clin Neuropsychol. 2003 Jan; 18(1):71-9.
Score: 0.004
-
Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. Cancer Lett. 1997 May 01; 115(1):25-30.
Score: 0.003
-
Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. Cancer Lett. 1996 Jan 02; 98(2):169-73.
Score: 0.003
-
Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser. Cancer Lett. 1995 Aug 01; 94(2):125-31.
Score: 0.003
-
Chromophore-enhanced laser-tumor tissue photothermal interaction using an 808-nm diode laser. Cancer Lett. 1995 Jan 06; 88(1):15-9.
Score: 0.002
-
Preserved cognitive skills in dementia of the Alzheimer type. Arch Neurol. 1994 Oct; 51(10):1040-6.
Score: 0.002